Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use ...
(Nasdaq: IONS) and partner AstraZeneca today announced that the CARDIO-TTRansform Phase 3 trial for eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet ...
1dOpinion
The End of Reading Is Here
Optimists once believed that universal literacy was inevitable. Now it seems that the age of reading might be a short anomaly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results